Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Filings indexed 425 across all filing types
Latest filing 2022-08-22 Share Issue/Capital Cha…
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Nghị quyết HĐQT về việc triển khai phương án phát hành cổ phiếu để trả cổ tức năm 2021
Share Issue/Capital Change Classification · 90% confidence The document is a formal disclosure by CÔNG TY CỔ PHẦN DƯỢC PHẨM BẾN TRE to the securities regulator and stock exchange announcing the implementation of a plan to issue new shares to pay dividends for the 2021 financial year. It includes detailed terms of the issuance (amount, ratio, purpose) and board resolution (Nghị quyết). This is not an annual or interim report but an announcement of a capital change via share issuance. Therefore, it fits the “Share Issue/Capital Change” category.
2022-08-22 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua lộ trình dự kiến thực hiện việc phát hành cổ phiếu để trả cổ tức, phát hành cổ phiếu ESOP
Share Issue/Capital Change Classification · 85% confidence The document is a formal announcement to the State Securities Commission and HoSE regarding the company’s approved plan and timeline for issuing shares to pay dividends, implement an ESOP program, and conduct a private placement. It includes the board resolution and detailed schedule for the share issuance process. This is not a full financial report, earnings release, or management/annual report; it is specifically about a share issue/capital change, fitting the definition of SHA.
2022-08-22 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua Quy chế phát hành ESOP
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement by the company to the State Securities Commission and the Ho Chi Minh City Stock Exchange regarding the criteria, Board resolution, regulations, and specific allocation of newly issued shares under an employee stock ownership plan (ESOP). It clearly relates to the issuance of new shares (capital change) rather than a general report or minutes, fitting the definition of a Share Issue/Capital Change announcement. Therefore, it should be classified under SHA.
2022-08-22 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua phương án phát hành ESOP
Share Issue/Capital Change Classification · 90% confidence The document is an official disclosure to the securities regulator and stock exchange concerning the implementation of a new share issuance plan (employee stock option program) and the related Board of Directors’ resolution. It details the number of shares to be issued, pricing, purpose, and compliance with foreign ownership limits—characteristics of a share issue/capital change announcement. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2022-08-22 Vietnamese
DBT: Nghị quyết HĐQT về việc thống nhất phê chuẩn giới hạn tín dụng
Capital/Financing Update Classification · 95% confidence The document is an official disclosure by Công ty Cổ phần Dược phẩm Bến Tre to the Vietnam SSC and HOSE regarding a request for a bank credit facility (credit limit) from Vietinbank. It includes the Board resolution approving the credit limit and details of the financing arrangement (credit limits for short‐term loans, guarantees, etc.). This is an update on the company’s financing activity, not a change in management or a regulatory attestation, and not a full financial report. It falls under capital/financing updates.
2022-08-15 Vietnamese
DBT: Báo cáo tình hình quản trị công ty 6 tháng đầu năm 2022
Governance Information Classification · 90% confidence The document is titled “BÁO CÁO TÌNH HÌNH QUẢN TRỊ CÔNG TY” (Report on Corporate Governance) for the six-month period of 2022. It details the governance model, activities and resolutions of the General Meeting of Shareholders, Board of Directors, Audit Committee, Board of Management, and related governance structures and practices. There are no financial statements as required for an interim/quarterly report, nor is it merely an announcement or certification. This matches the definition of Governance Information (CGR).
2022-08-01 Vietnamese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.